{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:56:24Z","timestamp":1760622984904,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 HL007605"],"award-info":[{"award-number":["T32 HL007605"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.pupt.2015.12.004","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T03:01:47Z","timestamp":1451962907000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5665-4060","authenticated-orcid":false,"given":"Leah J.","family":"Witt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5611-8305","authenticated-orcid":false,"given":"Carley","family":"Demchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Curran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Strek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2015.12.004_bib1","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1378\/chest.12-0741","article-title":"Diagnosis and treatment of connective tissue disease-associated interstitial lung disease","volume":"143","author":"Vij","year":"2013","journal-title":"CHEST J."},{"key":"10.1016\/j.pupt.2015.12.004_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(12)61079-4","article-title":"Interstitial lung disease in connective tissue disorders","volume":"380","author":"Fischer","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2015.12.004_bib3","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2015.12.004_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Care & Res."},{"key":"10.1016\/j.pupt.2015.12.004_bib5","first-page":"245","article-title":"Groupe d'Etudes et de Recherche sur les Maladies Orphelines P. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis","volume":"22","author":"Cottin","year":"2003","journal-title":"Eur. Respir. J. Official J. Eur. Soc. Clin. Respir. Physiol."},{"key":"10.1016\/j.pupt.2015.12.004_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-trna synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"QJM"},{"key":"10.1016\/j.pupt.2015.12.004_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","article-title":"Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?","volume":"176","author":"Kinder","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2015.12.004_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11926-003-0053-1","article-title":"Idiopathic inflammatory myopathies: A treatment update","volume":"5","author":"Oddis","year":"2003","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.pupt.2015.12.004_bib9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.rmed.2013.02.015","article-title":"A\u00a0retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis\/dermatomyositis","volume":"107","author":"Mira-Avendano","year":"2013","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2015.12.004_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-trna synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.pupt.2015.12.004_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.21895","article-title":"Interstitial lung disease in anti\u2013jo-1 patients with antisynthetase syndrome","volume":"65","author":"Marie","year":"2013","journal-title":"Arthritis care & Res."},{"key":"10.1016\/j.pupt.2015.12.004_bib12","first-page":"859","article-title":"The long-term outcome of anti-jo-1-positive inflammatory myopathies","volume":"251","author":"Sp\u00e4th","year":"2004","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.pupt.2015.12.004_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis rheumatism"},{"key":"10.1016\/j.pupt.2015.12.004_bib14","first-page":"1012","article-title":"Clinical evaluation of anti-aminoacyl trna synthetase antibodies in japanese patients with dermatomyositis","volume":"34","author":"Matsushita","year":"2007","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.pupt.2015.12.004_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/08916930500124023","article-title":"Polymyositis\/dermatomyositis and interstitial lung disease: A new therapeutic approach with t-cell-specific immunosuppressants","volume":"38","author":"Takada","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pupt.2015.12.004_bib16","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(99)01927-3","article-title":"Tacrolimus in refractory poly myositis with inter stitial lung disease","volume":"353","author":"Oddis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2015.12.004_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00007691-199512000-00007","article-title":"Mode of action of tacrolimus (fk506): molecular and cellular mechanisms","volume":"17","author":"Thomson","year":"1995","journal-title":"Ther. drug Monit."},{"key":"10.1016\/j.pupt.2015.12.004_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","article-title":"Randomised trial comparing tacrolimus (fk506) and cyclosporin in prevention of liver allograft rejection","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2015.12.004_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2015.12.004_bib20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ndt\/gfh739","article-title":"Group ftETvCMRTS. Efficacy and safety of tacrolimus compared with cyclosporin a microemulsion in renal transplantation: 2 year follow-up results","volume":"20","author":"Kr\u00e4mer","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.pupt.2015.12.004_bib21","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.pupt.2015.12.004_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00007.x","article-title":"Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients","volume":"48","author":"B\u00f6ttiger","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2015.12.004_bib23","first-page":"707","article-title":"Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis\/dermatomyositis","volume":"23","author":"Ochi","year":"2005","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.pupt.2015.12.004_bib24","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/art.21240","article-title":"Treatment of antisynthetase-associated interstitial lung disease with tacrolimus","volume":"52","author":"Wilkes","year":"2005","journal-title":"Arthritis rheumatism"},{"key":"10.1016\/j.pupt.2015.12.004_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10067-009-1358-x","article-title":"Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine","volume":"29","author":"Ando","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.pupt.2015.12.004_bib26","first-page":"213","article-title":"Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus","volume":"31","author":"Guglielmi","year":"2008","journal-title":"Eur. Respir. J. official J. Eur. Soc. Clin. Respir. Physiol."},{"issue":"1","key":"10.1016\/j.pupt.2015.12.004_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/keu166","article-title":"The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis","volume":"54","author":"Kurita","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.pupt.2015.12.004_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.iac.2012.07.001","article-title":"Immunosuppressive therapy for autoimmune lung diseases","volume":"32","author":"Meyer","year":"2012","journal-title":"Immunol. allergy Clin. N. Am."},{"key":"10.1016\/j.pupt.2015.12.004_bib29","doi-asserted-by":"crossref","DOI":"10.1378\/chest.1704626","article-title":"Safety and efficacy of tacrolimus in connective tissue disease-related interstitial lung disease","volume":"144","author":"Witt","year":"2013","journal-title":"CHEST J."},{"key":"10.1016\/j.pupt.2015.12.004_bib30","first-page":"A5776","article-title":"Successful treatment of dermatomyositis-related interstitial lung disease with tacrolimus plus azathioprine","volume":"187","author":"Curran","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2015.12.004_bib31","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.12-1044","article-title":"Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American college of chest physicians evidence-based clinical practice guidelines","volume":"142","author":"Baughman","year":"2012","journal-title":"CHEST J."},{"key":"10.1016\/j.pupt.2015.12.004_bib32","series-title":"Primary Prophylaxis for Pneumocystis Jirovecii Pneumonia in Patients with Connective Tissue Diseases. Seminars in Arthritis and Rheumatism","first-page":"497","author":"Vananuvat","year":"2011"},{"key":"10.1016\/j.pupt.2015.12.004_bib33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","article-title":"Mechanisms of clinically relevant drug interactions associated with tacrolimus","volume":"41","author":"Christians","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.pupt.2015.12.004_bib34","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","article-title":"Polymyositis-dermatomyositis-associated interstitial lung disease","volume":"164","author":"Douglas","year":"2001","journal-title":"Am. J. Respir. Crit. care Med."},{"key":"10.1016\/j.pupt.2015.12.004_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-012-2044-y","article-title":"Effects of tacrolimus on dermatomyositis and polymyositis: A prospective, open, non-randomized study of nine patients and a review of the literature","author":"Matsubara","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.pupt.2015.12.004_bib36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1183\/09031936.00163911","article-title":"Severe interstitial lung disease in connective tissue disease: Rituximab as rescue therapy","volume":"40","author":"Keir","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2015.12.004_bib37","first-page":"870","article-title":"azathioprine, and n-acetylcysteine for pulmonary fibrosis","volume":"367","author":"Prednisone","year":"2012","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553915300201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553915300201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T01:34:16Z","timestamp":1567474456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553915300201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":37,"alternative-id":["S1094553915300201"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2015.12.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"type":"print","value":"1094-5539"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2015.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}